EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for rare endocrine and metabolic disorders as well as musculoskeletal diseases.
EffRx Pharmaceuticals is a lean and agile, integrated, market-oriented biopharmaceutical company focused on niche therapeutics in Europe and in Switzerland. Our business strategy focuses on successfully shaping the late stage development and launch to market of therapeutics for patients suffering from niche and rare diseases.